O-067. Determination of ovulation by urinary hormone measurements with the ClearPlan Fertility Monitor: comparison to transvaginal ultrasound scans

Introduction

“…New immunoassay technology, combined with advances in electronics, has facilitated the development of the ClearPlan Easy™ Fertility Monitor* (developed by Unipath Ltd, UK), that uses these urinary hormones for detection of the fertile period. 6 Dr Keith May discusses the technology underlying the monitor and explains how the physiological information it provides can be of use, not only to the woman trying to conceive, but also to her physician. 7 Also in this publication, Professor Lawrence Severy addresses the importance of consumer acceptability of new technologies, such as home fertility monitors.…”